OBJECTIVE:

To seek evidences for the use of statins in cardiovascular diseases and their economic costs in the context Unified Health System (Sistema Único de Saúde).

METHODS:

This is an exploratory, a bibliographic and qualitative research performed by data collection method from the systematic review.

RESULTS:

It was observed that the treatment with statins have been considered cost-effective in preventing cardiovascular diseases for high-risk users, when there is reduction of outcomes at low cost, especially in secondary prevention.

CONCLUSION:

It is necessary to review the clinical guidelines about the application of the cost-effectiveness concept and the funding of basic and specialized component of statins (high cost) for the use of simvastatin and atorvastatin and their relationship with the primary and secondary prevention of cardiovascular diseases.

        · abstract in Portuguese | Spanish     · text in Portuguese | Spanish     · Spanish ( pdf ) | Portuguese ( pdf )